Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a

Regulatory Peptides

Volumn 172, Issue 1-3, 2011, Pages 69-76

  McGirr, Rebecca ^a   McFarland, Mark S ^b,c   McTavish, Jillian ^a   Luyt, Leonard G ^b,c   Dhanvantari, Savita ^a,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Biomarker; Cardiovascular; Ghrelin; GHS R1a; Heart; Imaging

Indexed keywords

CELL SURFACE RECEPTOR; FLUORESCEIN GHRELIN[1-18]; FLUORESCEIN ISOTHIOCYANATE; GHRELIN; HEXARELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REAGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONJUGATION; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR DENSITY; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; CHO CELLS; CRICETINAE; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; GHRELIN; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; RECEPTORS, GHRELIN;

EID: 80053576987     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.08.011     Document Type: Article

References (36)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
2. De Vriese C., Delporte C. Ghrelin: a new peptide regulating growth hormone release and food intake. Int J Biochem Cell Biol 2008, 40:1420-1424.
3. Hosoda H., Kojima M., Mizushima T., Shimizu S., Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003, 278:64-70.
4. Grossauer J., Kosol S., Schrank E., Zangger K. The peptide hormone ghrelin binds to membrane-mimetics via its octanoyl chain and an adjacent phenylalanine. Bioorg Med Chem 2010, 18:5483-5488.
5. Yang J., Zhao T.J., Goldstein J.L., Brown M.S. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc Natl Acad Sci USA 2008, 105:10750-10755.
6. Chollet C., Meyer K., Beck-Sickinger A.G. Ghrelin-a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. J Pept Sci 2009, 15:711-730.
7. Barnett B.P., Hwang Y., Taylor M.S., Kirchner H., Pfluger P.T., Bernard V., Lin Y.Y., Bowers E.M., Mukherjee C., Song W.J., Longo P.A., Leahy D.J., Hussain M.A., Tschop M.H., Boeke J.D., Cole P.A. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010, 330:1689-1692.
8. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
9. Leung P.K., Chow K.B., Lau P.N., Chu K.M., Chan C.B., Cheng C.H., Wise H. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 2007, 19:1011-1022.
10. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 2004, 279:53806-53817.
11. Floquet N., M'Kadmi C., Perahia D., Gagne D., Berge G., Marie J., Baneres J.L., Galleyrand J.C., Fehrentz J.A., Martinez J. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR). J Mol Biol 2010, 395:769-784.
12. Smith R.G., Van der Ploeg L.H., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997, 18:621-645.
13. Ueberberg B., Unger N., Saeger W., Mann K., Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009, 41:814-821.
14. 9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 2001, 134:143-149.
15. Rosita D., Dewit M.A., Luyt L.G. Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor. J Med Chem 2009, 52:2196-2203.
16. Behnam Azad B., Rota V.A., Breadner D., Dhanvantari S., Luyt L.G. Design, synthesis and in vitro characterization of glucagon-like peptide-1 derivatives for pancreatic beta cell imaging by SPECT. Bioorg Med Chem 2010, 18:1265-1272.
17. Camina J.P., Lodeiro M., Ischenko O., Martini A.C., Casanueva F.F. Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins. J Cell Physiol 2007, 213:187-200.
18. McGirr R., Ejbick C.E., Carter D.E., Andrews J.D., Nie Y., Friedman T.C., Dhanvantari S. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells. Endocrinology 2005, 146:4514-4523.
19. McGirr R., Hu S., Yee S.P., Kovacs M.S., Lee T.Y., Dhanvantari S. Towards PET imaging of intact pancreatic beta cell mass: a transgenic strategy. Mol Imaging Biol 2010, EPub ahead of print.
20. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeg L.H., Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 2000, 43:4370-4376.
21. Matsumoto M., Hosoda H., Kitajima Y., Morozumi N., Minamitake Y., Tanaka S., Matsuo H., Kojima M., Hayashi Y., Kangawa K. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 2001, 287:142-146.
22. Van Craenenbroeck M., Gregoire F., De Neef P., Robberecht P., Perret J. Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor. Peptides 2004, 25:959-965.
23. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004, 145:4997-5005.
24. Camina J.P., Carreira M.C., El Messari S., Llorens-Cortes C., Smith R.G., Casanueva F.F. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 2004, 145:930-940.
25. Bellmann-Sickert K., Baumann L., Beck-Sickinger A.G. Selective labelling of stromal cell-derived factor 1alpha with carboxyfluorescein to study receptor internalisation. J Pept Sci 2010, 16:568-574.
26. Gera L., Bawolak M.T., Roy C., Lodge R., Marceau F. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme. J Pharmacol Exp Ther 2011, 337:33-41.
27. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002, 159:1029-1037.
28. Beiras-Fernandez A., Kreth S., Weis F., Ledderose C., Pottinger T., Dieguez C., Beiras A., Reichart B. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides 2010, 10.1016/j.peptides.2010.08.019.
29. Wu R., Zhou M., Cui X., Simms H.H., Wang P. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol Heart Circ Physiol 2004, 287:H1296-H1302.
30. Lai K.C., Cheng C.H., Leung P.S. The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas. Pancreas 2007, 35:e1-e8.
31. Kageyama H., Funahashi H., Hirayama M., Takenoya F., Kita T., Kato S., Sakurai J., Lee E.Y., Inoue S., Date Y., Nakazato M., Kangawa K., Shioda S. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005, 126:67-71.
32. + signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 2007, 56:2319-2327.
33. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., Hosoda H., Kangawa K., Yada T. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006, 55:3486-3493.
34. Muccioli G., Baragli A., Granata R., Papotti M., Ghigo E. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007, 86:147-164.
35. Demers A., McNicoll N., Febbraio M., Servant M., Marleau S., Silverstein R., Ong H. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J 2004, 382:417-424.
36. Leyris J.P., Roux T., Trinquet E., Verdie P., Fehrentz J.A., Oueslati N., Douzon S., Bourrier E., Lamarque L., Gagne D., Galleyrand J.C., M'Kadmi C., Martinez J., Mary S., Baneres J.L., Marie J. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a. Anal Biochem 2011, 408:253-262.